Pulmicort Dreifa í eimgjafa 0,25 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,25 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,25 mg/ml

Pulmicort Dreifa í eimgjafa 0,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,5 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,5 mg/ml

Toilax Sýruþolin tafla og endaþarmsdreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

toilax sýruþolin tafla og endaþarmsdreifa

orion corporation - bisacodylum inn - sýruþolin tafla og endaþarmsdreifa

Toilax Endaþarmsdreifa 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

toilax endaþarmsdreifa 2 mg/ml

orion corporation - bisacodylum inn - endaþarmsdreifa - 2 mg/ml

Treo Freyðitafla 50 mg/ 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

treo freyðitafla 50 mg/ 500 mg

viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 50 mg/ 500 mg

Treo Hindbær Freyðitafla 500/50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

treo hindbær freyðitafla 500/50 mg

viatris aps - coffeinum; acidum acetylsalicylicum - freyðitafla - 500/50 mg

Elfabrio Evrópusambandið - íslenska - EMA (European Medicines Agency)

elfabrio

chiesi farmaceutici s.p.a - pegunigalsidase alfa - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - elfabrio is indicated for long-term enzyme replacement therapy in adult patients with a confirmed diagnosis of fabry disease (deficiency of alpha-galactosidase).

Mucomyst Freyðitafla 200 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mucomyst freyðitafla 200 mg

viatris aps - acetylcysteinum inn - freyðitafla - 200 mg

Treo Freyðitafla 500 mg/50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

treo freyðitafla 500 mg/50 mg

viatris aps - acidum acetylsalicylicum; coffeinum - freyðitafla - 500 mg/50 mg

Zoonotic Influenza Vaccine Seqirus Evrópusambandið - íslenska - EMA (European Medicines Agency)

zoonotic influenza vaccine seqirus

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - bóluefni - active immunisation against h5 subtype of influenza a virus.